Cedar Mountain Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.4K Sell
68
-126
-65% -$12K ﹤0.01% 582
2026
Q2
$16.4K Hold
194
– – ﹤0.01% 387
2026
Q1
$13.7K Buy
194
+172
+782% +$12.9K ﹤0.01% 380
2025
Q4
$1.74K Hold
22
– – ﹤0.01% 416
2025
Q3
$1.81K Buy
+22
New +$1.73K ﹤0.01% 432
2023
Q1
– Sell
-169
Closed -$12.2K – 317
2022
Q4
$12.2K Hold
169
– – ﹤0.01% 149
2022
Q3
$10K Hold
169
– – ﹤0.01% 159
2022
Q2
$11K Hold
169
– – ﹤0.01% 158
2022
Q1
$12K Hold
169
– – ﹤0.01% 159
2021
Q4
$11K Hold
169
– – ﹤0.01% 168
2021
Q3
$10K Buy
+169
New +$10.2K ﹤0.01% 166

Other funds holding MET

Cedar Mountain Advisors's MET Position: Q3 2026 in Review

Cedar Mountain Advisors reduced its MetLife (MET) stake by 65% in Q3 2026, selling an estimated $12K and leaving 68 shares worth $6.4K. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Cedar Mountain Advisors first reported a position in MET in Q3 2021 and has held it in 11 quarters since. The position peaked at $16.4K in Q2 2026. 580 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Cedar Mountain Advisors held 68 shares of MetLife worth $6.4K as of Q3 2026.
  • Cedar Mountain Advisors sold 126 MetLife shares in Q3 2026, an estimated $12K.
  • MetLife made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #582 holding.
  • Cedar Mountain Advisors first reported a position in MetLife in Q3 2021 and has held it in 11 quarters since.
  • Cedar Mountain Advisors's MetLife position peaked at $16.4K in Q2 2026.
  • 580 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.